Omkostningseffektivitet ved behandling af type 1-diabetes med insulinpumpe

Kirsten Nørgaard, Anna Sohlberg, Gordan Goodall

16 Citationer (Scopus)

Abstract

This study's aim was to project the long-term clinical and economic outcomes of continuous subcutaneous insulin infusion (CSII) treatment compared to multiple daily injections (MDI) in type 1 diabetes patients in Denmark.
Bidragets oversatte titel[Cost-effectiveness of continuous subcutaneous insulin infusion therapy for type 1 diabetes]
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind172
Udgave nummer27
Sider (fra-til)2020-5
Antal sider6
ISSN0041-5782
StatusUdgivet - 5 jul. 2010

Emneord

  • Adult
  • Cohort Studies
  • Cost-Benefit Analysis
  • Diabetes Complications
  • Diabetes Mellitus, Type 1
  • Female
  • Health Care Costs
  • Hemoglobin A, Glycosylated
  • Humans
  • Hypoglycemic Agents
  • Infusions, Subcutaneous
  • Insulin
  • Insulin Infusion Systems
  • Life Expectancy
  • Male
  • Prognosis
  • Quality-Adjusted Life Years
  • Treatment Outcome

Fingeraftryk

Dyk ned i forskningsemnerne om 'Omkostningseffektivitet ved behandling af type 1-diabetes med insulinpumpe'. Sammen danner de et unikt fingeraftryk.

Citationsformater